nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—ABCC2—type 2 diabetes mellitus	0.155	0.547	CbGaD
Irinotecan—CYP3A4—type 2 diabetes mellitus	0.0684	0.242	CbGaD
Irinotecan—ALB—type 2 diabetes mellitus	0.0596	0.211	CbGaD
Irinotecan—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.0361	0.0779	CbGbCtD
Irinotecan—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0298	0.0643	CbGbCtD
Irinotecan—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.027	0.0582	CbGbCtD
Irinotecan—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0249	0.0537	CbGbCtD
Irinotecan—BCHE—Ramipril—type 2 diabetes mellitus	0.0242	0.0522	CbGbCtD
Irinotecan—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.022	0.0474	CbGbCtD
Irinotecan—UGT1A1—Losartan—type 2 diabetes mellitus	0.0182	0.0393	CbGbCtD
Irinotecan—ALB—Gliclazide—type 2 diabetes mellitus	0.0174	0.0375	CbGbCtD
Irinotecan—ABCC1—Glyburide—type 2 diabetes mellitus	0.0164	0.0354	CbGbCtD
Irinotecan—ALB—Repaglinide—type 2 diabetes mellitus	0.0163	0.0352	CbGbCtD
Irinotecan—SLC22A3—Metformin—type 2 diabetes mellitus	0.0152	0.0328	CbGbCtD
Irinotecan—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0136	0.0294	CbGbCtD
Irinotecan—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0126	0.0272	CbGbCtD
Irinotecan—ABCC2—Glyburide—type 2 diabetes mellitus	0.0121	0.0262	CbGbCtD
Irinotecan—ALB—Valsartan—type 2 diabetes mellitus	0.012	0.026	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.012	0.0259	CbGbCtD
Irinotecan—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.012	0.0259	CbGbCtD
Irinotecan—ABCB1—Linagliptin—type 2 diabetes mellitus	0.012	0.0259	CbGbCtD
Irinotecan—ALB—Nateglinide—type 2 diabetes mellitus	0.0112	0.0241	CbGbCtD
Irinotecan—ABCG2—Glyburide—type 2 diabetes mellitus	0.011	0.0237	CbGbCtD
Irinotecan—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0107	0.0231	CbGbCtD
Irinotecan—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.009	0.0194	CbGbCtD
Irinotecan—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00773	0.0167	CbGbCtD
Irinotecan—ALB—Glyburide—type 2 diabetes mellitus	0.00756	0.0163	CbGbCtD
Irinotecan—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00719	0.0155	CbGbCtD
Irinotecan—ALB—Losartan—type 2 diabetes mellitus	0.00692	0.0149	CbGbCtD
Irinotecan—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0064	0.0138	CbGbCtD
Irinotecan—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00586	0.0126	CbGbCtD
Irinotecan—CYP3A5—Losartan—type 2 diabetes mellitus	0.00556	0.012	CbGbCtD
Irinotecan—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00531	0.0115	CbGbCtD
Irinotecan—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00512	0.011	CbGbCtD
Irinotecan—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00463	0.00998	CbGbCtD
Irinotecan—ABCB1—Glyburide—type 2 diabetes mellitus	0.00396	0.00853	CbGbCtD
Irinotecan—ABCB1—Losartan—type 2 diabetes mellitus	0.00362	0.0078	CbGbCtD
Irinotecan—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00351	0.00757	CbGbCtD
Irinotecan—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00336	0.00725	CbGbCtD
Irinotecan—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00336	0.00725	CbGbCtD
Irinotecan—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00318	0.00686	CbGbCtD
Irinotecan—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00237	0.00511	CbGbCtD
Irinotecan—CYP3A4—Losartan—type 2 diabetes mellitus	0.00217	0.00467	CbGbCtD
Irinotecan—TOP1MT—adipose tissue—type 2 diabetes mellitus	0.00117	0.0418	CbGeAlD
Irinotecan—Topotecan—CYP3A4—type 2 diabetes mellitus	0.00113	1	CrCbGaD
Irinotecan—TOP1—islet of Langerhans—type 2 diabetes mellitus	0.000971	0.0346	CbGeAlD
Irinotecan—CES2—islet of Langerhans—type 2 diabetes mellitus	0.000881	0.0313	CbGeAlD
Irinotecan—TOP1—retina—type 2 diabetes mellitus	0.000831	0.0295	CbGeAlD
Irinotecan—TOP1MT—liver—type 2 diabetes mellitus	0.000824	0.0293	CbGeAlD
Irinotecan—TOP1—nephron tubule—type 2 diabetes mellitus	0.000782	0.0278	CbGeAlD
Irinotecan—UGT1A9—kidney—type 2 diabetes mellitus	0.000773	0.0275	CbGeAlD
Irinotecan—CES2—retina—type 2 diabetes mellitus	0.000753	0.0268	CbGeAlD
Irinotecan—ACHE—islet of Langerhans—type 2 diabetes mellitus	0.000726	0.0258	CbGeAlD
Irinotecan—CES2—nephron tubule—type 2 diabetes mellitus	0.000709	0.0252	CbGeAlD
Irinotecan—TOP1—pancreas—type 2 diabetes mellitus	0.000683	0.0243	CbGeAlD
Irinotecan—TOP1—cortex of kidney—type 2 diabetes mellitus	0.00067	0.0238	CbGeAlD
Irinotecan—CES2—cardiovascular system—type 2 diabetes mellitus	0.000637	0.0227	CbGeAlD
Irinotecan—CES2—kidney—type 2 diabetes mellitus	0.000623	0.0222	CbGeAlD
Irinotecan—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000622	0.0221	CbGeAlD
Irinotecan—TOP1—adipose tissue—type 2 diabetes mellitus	0.00062	0.022	CbGeAlD
Irinotecan—CES2—pancreas—type 2 diabetes mellitus	0.000619	0.022	CbGeAlD
Irinotecan—CES2—cortex of kidney—type 2 diabetes mellitus	0.000607	0.0216	CbGeAlD
Irinotecan—CES2—adipose tissue—type 2 diabetes mellitus	0.000562	0.02	CbGeAlD
Irinotecan—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000533	0.0189	CbGeAlD
Irinotecan—UGT1A1—kidney—type 2 diabetes mellitus	0.00053	0.0189	CbGeAlD
Irinotecan—CES1—cardiovascular system—type 2 diabetes mellitus	0.000525	0.0187	CbGeAlD
Irinotecan—UGT1A9—liver—type 2 diabetes mellitus	0.000489	0.0174	CbGeAlD
Irinotecan—CES1—adipose tissue—type 2 diabetes mellitus	0.000463	0.0165	CbGeAlD
Irinotecan—SLCO1B1—kidney—type 2 diabetes mellitus	0.000441	0.0157	CbGeAlD
Irinotecan—TOP1—liver—type 2 diabetes mellitus	0.000435	0.0155	CbGeAlD
Irinotecan—CYP3A7—liver—type 2 diabetes mellitus	0.000407	0.0145	CbGeAlD
Irinotecan—CES2—liver—type 2 diabetes mellitus	0.000394	0.014	CbGeAlD
Irinotecan—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000381	0.0135	CbGeAlD
Irinotecan—SLC22A3—kidney—type 2 diabetes mellitus	0.000356	0.0127	CbGeAlD
Irinotecan—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000346	0.0123	CbGeAlD
Irinotecan—UGT1A1—liver—type 2 diabetes mellitus	0.000335	0.0119	CbGeAlD
Irinotecan—ABCC2—kidney—type 2 diabetes mellitus	0.000334	0.0119	CbGeAlD
Irinotecan—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000326	0.0116	CbGeAlD
Irinotecan—CES1—liver—type 2 diabetes mellitus	0.000325	0.0115	CbGeAlD
Irinotecan—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.000321	0.0114	CbGeAlD
Irinotecan—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.00032	0.0114	CbGeAlD
Irinotecan—BCHE—nephron tubule—type 2 diabetes mellitus	0.000287	0.0102	CbGeAlD
Irinotecan—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.000287	0.0102	CbGeAlD
Irinotecan—SLCO1B1—liver—type 2 diabetes mellitus	0.000279	0.00992	CbGeAlD
Irinotecan—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000278	0.00987	CbGeAlD
Irinotecan—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000265	0.00944	CbGeAlD
Irinotecan—BCHE—cardiovascular system—type 2 diabetes mellitus	0.000258	0.00917	CbGeAlD
Irinotecan—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000258	0.00916	CbGeAlD
Irinotecan—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000256	0.00911	CbGeAlD
Irinotecan—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.00023	0.00818	CbGeAlD
Irinotecan—BCHE—adipose tissue—type 2 diabetes mellitus	0.000227	0.00809	CbGeAlD
Irinotecan—CYP3A5—kidney—type 2 diabetes mellitus	0.000226	0.00805	CbGeAlD
Irinotecan—ALB—liver—type 2 diabetes mellitus	0.000226	0.00802	CbGeAlD
Irinotecan—SLC22A3—liver—type 2 diabetes mellitus	0.000225	0.00801	CbGeAlD
Irinotecan—CYP2B6—kidney—type 2 diabetes mellitus	0.000225	0.008	CbGeAlD
Irinotecan—CYP3A5—pancreas—type 2 diabetes mellitus	0.000225	0.008	CbGeAlD
Irinotecan—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.00022	0.00784	CbGeAlD
Irinotecan—ABCG2—adipose tissue—type 2 diabetes mellitus	0.00022	0.00782	CbGeAlD
Irinotecan—ABCC2—liver—type 2 diabetes mellitus	0.000211	0.00752	CbGeAlD
Irinotecan—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000204	0.00726	CbGeAlD
Irinotecan—ABCC1—liver—type 2 diabetes mellitus	0.000186	0.00662	CbGeAlD
Irinotecan—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.00017	0.00605	CbGeAlD
Irinotecan—CYP3A4—kidney—type 2 diabetes mellitus	0.00017	0.00604	CbGeAlD
Irinotecan—BCHE—liver—type 2 diabetes mellitus	0.000159	0.00567	CbGeAlD
Irinotecan—ABCG2—liver—type 2 diabetes mellitus	0.000154	0.00548	CbGeAlD
Irinotecan—ABCB1—retina—type 2 diabetes mellitus	0.000145	0.00517	CbGeAlD
Irinotecan—CYP3A5—liver—type 2 diabetes mellitus	0.000143	0.00509	CbGeAlD
Irinotecan—CYP2B6—liver—type 2 diabetes mellitus	0.000142	0.00506	CbGeAlD
Irinotecan—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000137	0.00487	CbGeAlD
Irinotecan—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000123	0.00437	CbGeAlD
Irinotecan—ABCB1—kidney—type 2 diabetes mellitus	0.00012	0.00428	CbGeAlD
Irinotecan—ABCB1—pancreas—type 2 diabetes mellitus	0.000119	0.00425	CbGeAlD
Irinotecan—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000117	0.00417	CbGeAlD
Irinotecan—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000108	0.00386	CbGeAlD
Irinotecan—CYP3A4—liver—type 2 diabetes mellitus	0.000107	0.00382	CbGeAlD
Irinotecan—Dizziness—Sitagliptin—type 2 diabetes mellitus	8.68e-05	0.000644	CcSEcCtD
Irinotecan—Somnolence—Gliclazide—type 2 diabetes mellitus	8.67e-05	0.000643	CcSEcCtD
Irinotecan—Hypertension—Metformin—type 2 diabetes mellitus	8.63e-05	0.00064	CcSEcCtD
Irinotecan—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000637	CcSEcCtD
Irinotecan—Back pain—Losartan—type 2 diabetes mellitus	8.58e-05	0.000637	CcSEcCtD
Irinotecan—Abdominal pain—Glyburide—type 2 diabetes mellitus	8.58e-05	0.000637	CcSEcCtD
Irinotecan—Dyspepsia—Gliclazide—type 2 diabetes mellitus	8.58e-05	0.000636	CcSEcCtD
Irinotecan—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	8.56e-05	0.000635	CcSEcCtD
Irinotecan—Anorexia—Valsartan—type 2 diabetes mellitus	8.54e-05	0.000633	CcSEcCtD
Irinotecan—Muscle spasms—Losartan—type 2 diabetes mellitus	8.53e-05	0.000633	CcSEcCtD
Irinotecan—Asthenia—Bromocriptine—type 2 diabetes mellitus	8.52e-05	0.000632	CcSEcCtD
Irinotecan—Malaise—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.000631	CcSEcCtD
Irinotecan—Vertigo—Irbesartan—type 2 diabetes mellitus	8.47e-05	0.000628	CcSEcCtD
Irinotecan—Headache—Pioglitazone—type 2 diabetes mellitus	8.47e-05	0.000628	CcSEcCtD
Irinotecan—Syncope—Irbesartan—type 2 diabetes mellitus	8.46e-05	0.000627	CcSEcCtD
Irinotecan—Leukopenia—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.000626	CcSEcCtD
Irinotecan—Visual impairment—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000625	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	8.42e-05	0.000624	CcSEcCtD
Irinotecan—Discomfort—Metformin—type 2 diabetes mellitus	8.41e-05	0.000623	CcSEcCtD
Irinotecan—Fatigue—Gliclazide—type 2 diabetes mellitus	8.4e-05	0.000623	CcSEcCtD
Irinotecan—Nausea—Glipizide—type 2 diabetes mellitus	8.38e-05	0.000621	CcSEcCtD
Irinotecan—Vomiting—Glimepiride—type 2 diabetes mellitus	8.37e-05	0.000621	CcSEcCtD
Irinotecan—Hypotension—Valsartan—type 2 diabetes mellitus	8.37e-05	0.000621	CcSEcCtD
Irinotecan—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.34e-05	0.000619	CcSEcCtD
Irinotecan—Pain—Gliclazide—type 2 diabetes mellitus	8.34e-05	0.000618	CcSEcCtD
Irinotecan—Constipation—Gliclazide—type 2 diabetes mellitus	8.34e-05	0.000618	CcSEcCtD
Irinotecan—Rash—Glimepiride—type 2 diabetes mellitus	8.3e-05	0.000616	CcSEcCtD
Irinotecan—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.29e-05	0.000615	CcSEcCtD
Irinotecan—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	8.29e-05	0.000615	CcSEcCtD
Irinotecan—Rash—Sitagliptin—type 2 diabetes mellitus	8.27e-05	0.000614	CcSEcCtD
Irinotecan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.27e-05	0.000613	CcSEcCtD
Irinotecan—Headache—Glimepiride—type 2 diabetes mellitus	8.25e-05	0.000612	CcSEcCtD
Irinotecan—Ill-defined disorder—Losartan—type 2 diabetes mellitus	8.23e-05	0.000611	CcSEcCtD
Irinotecan—Cough—Irbesartan—type 2 diabetes mellitus	8.23e-05	0.00061	CcSEcCtD
Irinotecan—Headache—Sitagliptin—type 2 diabetes mellitus	8.22e-05	0.00061	CcSEcCtD
Irinotecan—Anaemia—Losartan—type 2 diabetes mellitus	8.2e-05	0.000608	CcSEcCtD
Irinotecan—Oedema—Metformin—type 2 diabetes mellitus	8.16e-05	0.000605	CcSEcCtD
Irinotecan—Hypertension—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000604	CcSEcCtD
Irinotecan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.13e-05	0.000603	CcSEcCtD
Irinotecan—Flushing—Ramipril—type 2 diabetes mellitus	8.11e-05	0.000602	CcSEcCtD
Irinotecan—Infection—Metformin—type 2 diabetes mellitus	8.1e-05	0.000601	CcSEcCtD
Irinotecan—Insomnia—Valsartan—type 2 diabetes mellitus	8.1e-05	0.000601	CcSEcCtD
Irinotecan—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.04e-05	0.000596	CcSEcCtD
Irinotecan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.03e-05	0.000596	CcSEcCtD
Irinotecan—Shock—Metformin—type 2 diabetes mellitus	8.02e-05	0.000595	CcSEcCtD
Irinotecan—Insomnia—Orlistat—type 2 diabetes mellitus	8e-05	0.000594	CcSEcCtD
Irinotecan—Malaise—Losartan—type 2 diabetes mellitus	8e-05	0.000594	CcSEcCtD
Irinotecan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8e-05	0.000593	CcSEcCtD
Irinotecan—Nervous system disorder—Metformin—type 2 diabetes mellitus	8e-05	0.000593	CcSEcCtD
Irinotecan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.99e-05	0.000592	CcSEcCtD
Irinotecan—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.98e-05	0.000592	CcSEcCtD
Irinotecan—Vertigo—Losartan—type 2 diabetes mellitus	7.97e-05	0.000591	CcSEcCtD
Irinotecan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.97e-05	0.000591	CcSEcCtD
Irinotecan—Somnolence—Valsartan—type 2 diabetes mellitus	7.96e-05	0.000591	CcSEcCtD
Irinotecan—Syncope—Losartan—type 2 diabetes mellitus	7.96e-05	0.00059	CcSEcCtD
Irinotecan—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.95e-05	0.000589	CcSEcCtD
Irinotecan—Leukopenia—Losartan—type 2 diabetes mellitus	7.94e-05	0.000589	CcSEcCtD
Irinotecan—Discomfort—Irbesartan—type 2 diabetes mellitus	7.93e-05	0.000588	CcSEcCtD
Irinotecan—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.9e-05	0.000586	CcSEcCtD
Irinotecan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.88e-05	0.000585	CcSEcCtD
Irinotecan—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.88e-05	0.000585	CcSEcCtD
Irinotecan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.88e-05	0.000584	CcSEcCtD
Irinotecan—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.85e-05	0.000582	CcSEcCtD
Irinotecan—Nausea—Glimepiride—type 2 diabetes mellitus	7.82e-05	0.00058	CcSEcCtD
Irinotecan—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000579	CcSEcCtD
Irinotecan—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.8e-05	0.000579	CcSEcCtD
Irinotecan—Nausea—Sitagliptin—type 2 diabetes mellitus	7.79e-05	0.000578	CcSEcCtD
Irinotecan—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.79e-05	0.000578	CcSEcCtD
Irinotecan—Asthenia—Glyburide—type 2 diabetes mellitus	7.79e-05	0.000578	CcSEcCtD
Irinotecan—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.79e-05	0.000577	CcSEcCtD
Irinotecan—Anorexia—Metformin—type 2 diabetes mellitus	7.77e-05	0.000577	CcSEcCtD
Irinotecan—Cough—Losartan—type 2 diabetes mellitus	7.74e-05	0.000574	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.73e-05	0.000573	CcSEcCtD
Irinotecan—Alopecia—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000573	CcSEcCtD
Irinotecan—Fatigue—Valsartan—type 2 diabetes mellitus	7.72e-05	0.000573	CcSEcCtD
Irinotecan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.71e-05	0.000572	CcSEcCtD
Irinotecan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.71e-05	0.000572	CcSEcCtD
Irinotecan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000571	CcSEcCtD
Irinotecan—Oedema—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000571	CcSEcCtD
Irinotecan—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.69e-05	0.000571	CcSEcCtD
Irinotecan—Constipation—Valsartan—type 2 diabetes mellitus	7.66e-05	0.000568	CcSEcCtD
Irinotecan—Infection—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000567	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.64e-05	0.000567	CcSEcCtD
Irinotecan—Fatigue—Orlistat—type 2 diabetes mellitus	7.63e-05	0.000566	CcSEcCtD
Irinotecan—Hypotension—Metformin—type 2 diabetes mellitus	7.62e-05	0.000565	CcSEcCtD
Irinotecan—ABCB1—liver—type 2 diabetes mellitus	7.6e-05	0.0027	CbGeAlD
Irinotecan—Shock—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000562	CcSEcCtD
Irinotecan—Pain—Orlistat—type 2 diabetes mellitus	7.57e-05	0.000561	CcSEcCtD
Irinotecan—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.55e-05	0.00056	CcSEcCtD
Irinotecan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.00056	CcSEcCtD
Irinotecan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000559	CcSEcCtD
Irinotecan—Rash—Bromocriptine—type 2 diabetes mellitus	7.49e-05	0.000555	CcSEcCtD
Irinotecan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.48e-05	0.000555	CcSEcCtD
Irinotecan—Discomfort—Losartan—type 2 diabetes mellitus	7.47e-05	0.000554	CcSEcCtD
Irinotecan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000552	CcSEcCtD
Irinotecan—Headache—Bromocriptine—type 2 diabetes mellitus	7.44e-05	0.000552	CcSEcCtD
Irinotecan—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.43e-05	0.000551	CcSEcCtD
Irinotecan—Anorexia—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.000544	CcSEcCtD
Irinotecan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.32e-05	0.000543	CcSEcCtD
Irinotecan—Paraesthesia—Metformin—type 2 diabetes mellitus	7.32e-05	0.000543	CcSEcCtD
Irinotecan—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000543	CcSEcCtD
Irinotecan—Confusional state—Losartan—type 2 diabetes mellitus	7.3e-05	0.000542	CcSEcCtD
Irinotecan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.29e-05	0.000541	CcSEcCtD
Irinotecan—Dyspnoea—Metformin—type 2 diabetes mellitus	7.27e-05	0.000539	CcSEcCtD
Irinotecan—Somnolence—Metformin—type 2 diabetes mellitus	7.25e-05	0.000538	CcSEcCtD
Irinotecan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.24e-05	0.000537	CcSEcCtD
Irinotecan—Oedema—Losartan—type 2 diabetes mellitus	7.24e-05	0.000537	CcSEcCtD
Irinotecan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.24e-05	0.000537	CcSEcCtD
Irinotecan—Infection—Losartan—type 2 diabetes mellitus	7.2e-05	0.000534	CcSEcCtD
Irinotecan—Hypotension—Irbesartan—type 2 diabetes mellitus	7.19e-05	0.000533	CcSEcCtD
Irinotecan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.18e-05	0.000533	CcSEcCtD
Irinotecan—Dyspepsia—Metformin—type 2 diabetes mellitus	7.18e-05	0.000532	CcSEcCtD
Irinotecan—Shock—Losartan—type 2 diabetes mellitus	7.13e-05	0.000529	CcSEcCtD
Irinotecan—Nervous system disorder—Losartan—type 2 diabetes mellitus	7.1e-05	0.000527	CcSEcCtD
Irinotecan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.09e-05	0.000526	CcSEcCtD
Irinotecan—Decreased appetite—Metformin—type 2 diabetes mellitus	7.09e-05	0.000526	CcSEcCtD
Irinotecan—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.08e-05	0.000525	CcSEcCtD
Irinotecan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000524	CcSEcCtD
Irinotecan—Nausea—Bromocriptine—type 2 diabetes mellitus	7.05e-05	0.000523	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.04e-05	0.000522	CcSEcCtD
Irinotecan—Fatigue—Metformin—type 2 diabetes mellitus	7.03e-05	0.000522	CcSEcCtD
Irinotecan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7e-05	0.000519	CcSEcCtD
Irinotecan—Abdominal pain—Orlistat—type 2 diabetes mellitus	7e-05	0.000519	CcSEcCtD
Irinotecan—Body temperature increased—Orlistat—type 2 diabetes mellitus	7e-05	0.000519	CcSEcCtD
Irinotecan—Asthenia—Gliclazide—type 2 diabetes mellitus	6.99e-05	0.000519	CcSEcCtD
Irinotecan—Constipation—Metformin—type 2 diabetes mellitus	6.97e-05	0.000517	CcSEcCtD
Irinotecan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.000513	CcSEcCtD
Irinotecan—Anorexia—Losartan—type 2 diabetes mellitus	6.9e-05	0.000512	CcSEcCtD
Irinotecan—Vomiting—Glyburide—type 2 diabetes mellitus	6.9e-05	0.000512	CcSEcCtD
Irinotecan—Malaise—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000509	CcSEcCtD
Irinotecan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000509	CcSEcCtD
Irinotecan—Rash—Glyburide—type 2 diabetes mellitus	6.84e-05	0.000508	CcSEcCtD
Irinotecan—Somnolence—Irbesartan—type 2 diabetes mellitus	6.84e-05	0.000507	CcSEcCtD
Irinotecan—Dermatitis—Glyburide—type 2 diabetes mellitus	6.84e-05	0.000507	CcSEcCtD
Irinotecan—Vertigo—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000507	CcSEcCtD
Irinotecan—Syncope—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000506	CcSEcCtD
Irinotecan—Leukopenia—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000505	CcSEcCtD
Irinotecan—Headache—Glyburide—type 2 diabetes mellitus	6.8e-05	0.000504	CcSEcCtD
Irinotecan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.77e-05	0.000503	CcSEcCtD
Irinotecan—Hypotension—Losartan—type 2 diabetes mellitus	6.77e-05	0.000502	CcSEcCtD
Irinotecan—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.72e-05	0.000498	CcSEcCtD
Irinotecan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000496	CcSEcCtD
Irinotecan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000496	CcSEcCtD
Irinotecan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.67e-05	0.000495	CcSEcCtD
Irinotecan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.67e-05	0.000495	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000493	CcSEcCtD
Irinotecan—Cough—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000493	CcSEcCtD
Irinotecan—Fatigue—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000492	CcSEcCtD
Irinotecan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.6e-05	0.000489	CcSEcCtD
Irinotecan—Constipation—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000488	CcSEcCtD
Irinotecan—Pain—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000488	CcSEcCtD
Irinotecan—Insomnia—Losartan—type 2 diabetes mellitus	6.55e-05	0.000486	CcSEcCtD
Irinotecan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.52e-05	0.000484	CcSEcCtD
Irinotecan—Paraesthesia—Losartan—type 2 diabetes mellitus	6.5e-05	0.000482	CcSEcCtD
Irinotecan—Dyspnoea—Losartan—type 2 diabetes mellitus	6.46e-05	0.000479	CcSEcCtD
Irinotecan—Nausea—Glyburide—type 2 diabetes mellitus	6.45e-05	0.000478	CcSEcCtD
Irinotecan—Abdominal pain—Metformin—type 2 diabetes mellitus	6.45e-05	0.000478	CcSEcCtD
Irinotecan—Dizziness—Gliclazide—type 2 diabetes mellitus	6.45e-05	0.000478	CcSEcCtD
Irinotecan—Somnolence—Losartan—type 2 diabetes mellitus	6.44e-05	0.000478	CcSEcCtD
Irinotecan—Asthenia—Valsartan—type 2 diabetes mellitus	6.43e-05	0.000477	CcSEcCtD
Irinotecan—Discomfort—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000475	CcSEcCtD
Irinotecan—Dyspepsia—Losartan—type 2 diabetes mellitus	6.38e-05	0.000473	CcSEcCtD
Irinotecan—Asthenia—Orlistat—type 2 diabetes mellitus	6.35e-05	0.000471	CcSEcCtD
Irinotecan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.34e-05	0.00047	CcSEcCtD
Irinotecan—Decreased appetite—Losartan—type 2 diabetes mellitus	6.3e-05	0.000467	CcSEcCtD
Irinotecan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.29e-05	0.000467	CcSEcCtD
Irinotecan—Confusional state—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000464	CcSEcCtD
Irinotecan—Fatigue—Losartan—type 2 diabetes mellitus	6.24e-05	0.000463	CcSEcCtD
Irinotecan—Oedema—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000461	CcSEcCtD
Irinotecan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000461	CcSEcCtD
Irinotecan—Vomiting—Gliclazide—type 2 diabetes mellitus	6.2e-05	0.00046	CcSEcCtD
Irinotecan—Pain—Losartan—type 2 diabetes mellitus	6.19e-05	0.000459	CcSEcCtD
Irinotecan—Constipation—Losartan—type 2 diabetes mellitus	6.19e-05	0.000459	CcSEcCtD
Irinotecan—Rash—Gliclazide—type 2 diabetes mellitus	6.15e-05	0.000456	CcSEcCtD
Irinotecan—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.14e-05	0.000455	CcSEcCtD
Irinotecan—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.13e-05	0.000454	CcSEcCtD
Irinotecan—Shock—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000453	CcSEcCtD
Irinotecan—Headache—Gliclazide—type 2 diabetes mellitus	6.11e-05	0.000453	CcSEcCtD
Irinotecan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000452	CcSEcCtD
Irinotecan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.08e-05	0.000451	CcSEcCtD
Irinotecan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.08e-05	0.000451	CcSEcCtD
Irinotecan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000451	CcSEcCtD
Irinotecan—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.05e-05	0.000449	CcSEcCtD
Irinotecan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6e-05	0.000445	CcSEcCtD
Irinotecan—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.97e-05	0.000443	CcSEcCtD
Irinotecan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.92e-05	0.000439	CcSEcCtD
Irinotecan—Dizziness—Valsartan—type 2 diabetes mellitus	5.92e-05	0.000439	CcSEcCtD
Irinotecan—Anorexia—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000439	CcSEcCtD
Irinotecan—Dizziness—Orlistat—type 2 diabetes mellitus	5.85e-05	0.000434	CcSEcCtD
Irinotecan—Asthenia—Metformin—type 2 diabetes mellitus	5.85e-05	0.000434	CcSEcCtD
Irinotecan—Hypotension—Ramipril—type 2 diabetes mellitus	5.8e-05	0.00043	CcSEcCtD
Irinotecan—Nausea—Gliclazide—type 2 diabetes mellitus	5.79e-05	0.000429	CcSEcCtD
Irinotecan—Body temperature increased—Losartan—type 2 diabetes mellitus	5.73e-05	0.000425	CcSEcCtD
Irinotecan—Abdominal pain—Losartan—type 2 diabetes mellitus	5.73e-05	0.000425	CcSEcCtD
Irinotecan—Vomiting—Valsartan—type 2 diabetes mellitus	5.69e-05	0.000422	CcSEcCtD
Irinotecan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000421	CcSEcCtD
Irinotecan—Rash—Valsartan—type 2 diabetes mellitus	5.65e-05	0.000419	CcSEcCtD
Irinotecan—Dermatitis—Valsartan—type 2 diabetes mellitus	5.64e-05	0.000418	CcSEcCtD
Irinotecan—Vomiting—Orlistat—type 2 diabetes mellitus	5.63e-05	0.000417	CcSEcCtD
Irinotecan—Insomnia—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000417	CcSEcCtD
Irinotecan—Headache—Valsartan—type 2 diabetes mellitus	5.61e-05	0.000416	CcSEcCtD
Irinotecan—Diarrhoea—Metformin—type 2 diabetes mellitus	5.58e-05	0.000414	CcSEcCtD
Irinotecan—Rash—Orlistat—type 2 diabetes mellitus	5.58e-05	0.000414	CcSEcCtD
Irinotecan—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.58e-05	0.000414	CcSEcCtD
Irinotecan—Dermatitis—Orlistat—type 2 diabetes mellitus	5.57e-05	0.000413	CcSEcCtD
Irinotecan—Headache—Orlistat—type 2 diabetes mellitus	5.54e-05	0.000411	CcSEcCtD
Irinotecan—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000411	CcSEcCtD
Irinotecan—Asthenia—Irbesartan—type 2 diabetes mellitus	5.52e-05	0.00041	CcSEcCtD
Irinotecan—Somnolence—Ramipril—type 2 diabetes mellitus	5.52e-05	0.00041	CcSEcCtD
Irinotecan—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000405	CcSEcCtD
Irinotecan—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.4e-05	0.0004	CcSEcCtD
Irinotecan—Dizziness—Metformin—type 2 diabetes mellitus	5.39e-05	0.0004	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000398	CcSEcCtD
Irinotecan—Fatigue—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000397	CcSEcCtD
Irinotecan—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.34e-05	0.000396	CcSEcCtD
Irinotecan—Nausea—Valsartan—type 2 diabetes mellitus	5.32e-05	0.000395	CcSEcCtD
Irinotecan—Constipation—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000394	CcSEcCtD
Irinotecan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000391	CcSEcCtD
Irinotecan—Nausea—Orlistat—type 2 diabetes mellitus	5.26e-05	0.00039	CcSEcCtD
Irinotecan—Asthenia—Losartan—type 2 diabetes mellitus	5.2e-05	0.000385	CcSEcCtD
Irinotecan—Vomiting—Metformin—type 2 diabetes mellitus	5.19e-05	0.000385	CcSEcCtD
Irinotecan—Rash—Metformin—type 2 diabetes mellitus	5.14e-05	0.000381	CcSEcCtD
Irinotecan—Dermatitis—Metformin—type 2 diabetes mellitus	5.14e-05	0.000381	CcSEcCtD
Irinotecan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.12e-05	0.00038	CcSEcCtD
Irinotecan—Headache—Metformin—type 2 diabetes mellitus	5.11e-05	0.000379	CcSEcCtD
Irinotecan—Dizziness—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000377	CcSEcCtD
Irinotecan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000377	CcSEcCtD
Irinotecan—Diarrhoea—Losartan—type 2 diabetes mellitus	4.96e-05	0.000368	CcSEcCtD
Irinotecan—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.91e-05	0.000364	CcSEcCtD
Irinotecan—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.91e-05	0.000364	CcSEcCtD
Irinotecan—Vomiting—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000363	CcSEcCtD
Irinotecan—Rash—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.00036	CcSEcCtD
Irinotecan—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.00036	CcSEcCtD
Irinotecan—Nausea—Metformin—type 2 diabetes mellitus	4.84e-05	0.000359	CcSEcCtD
Irinotecan—Headache—Irbesartan—type 2 diabetes mellitus	4.82e-05	0.000358	CcSEcCtD
Irinotecan—Dizziness—Losartan—type 2 diabetes mellitus	4.79e-05	0.000355	CcSEcCtD
Irinotecan—Vomiting—Losartan—type 2 diabetes mellitus	4.61e-05	0.000342	CcSEcCtD
Irinotecan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000339	CcSEcCtD
Irinotecan—Nausea—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000339	CcSEcCtD
Irinotecan—Rash—Losartan—type 2 diabetes mellitus	4.57e-05	0.000339	CcSEcCtD
Irinotecan—Dermatitis—Losartan—type 2 diabetes mellitus	4.56e-05	0.000338	CcSEcCtD
Irinotecan—Headache—Losartan—type 2 diabetes mellitus	4.54e-05	0.000337	CcSEcCtD
Irinotecan—Asthenia—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000331	CcSEcCtD
Irinotecan—Nausea—Losartan—type 2 diabetes mellitus	4.3e-05	0.000319	CcSEcCtD
Irinotecan—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000315	CcSEcCtD
Irinotecan—Dizziness—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000305	CcSEcCtD
Irinotecan—Vomiting—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000293	CcSEcCtD
Irinotecan—Rash—Ramipril—type 2 diabetes mellitus	3.92e-05	0.00029	CcSEcCtD
Irinotecan—Dermatitis—Ramipril—type 2 diabetes mellitus	3.91e-05	0.00029	CcSEcCtD
Irinotecan—Headache—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000289	CcSEcCtD
Irinotecan—Nausea—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000274	CcSEcCtD
Irinotecan—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	3.09e-06	3.46e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	3.09e-06	3.45e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	3.08e-06	3.44e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NOS3—type 2 diabetes mellitus	3.08e-06	3.44e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	3.08e-06	3.44e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	3.07e-06	3.43e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—INS—type 2 diabetes mellitus	3.05e-06	3.41e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—INS—type 2 diabetes mellitus	3.05e-06	3.41e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	3.04e-06	3.4e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.03e-06	3.39e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	3.03e-06	3.39e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	3.03e-06	3.38e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	3.03e-06	3.38e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	3.01e-06	3.37e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	3e-06	3.36e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	3e-06	3.35e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	3e-06	3.35e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	3e-06	3.35e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	2.97e-06	3.32e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	2.97e-06	3.32e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	2.97e-06	3.31e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	2.97e-06	3.31e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ALB—type 2 diabetes mellitus	2.95e-06	3.29e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—INS—type 2 diabetes mellitus	2.94e-06	3.29e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	2.93e-06	3.27e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2.92e-06	3.26e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2.92e-06	3.26e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2.92e-06	3.26e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	2.91e-06	3.25e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.91e-06	3.25e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	2.9e-06	3.24e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	2.89e-06	3.23e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.88e-06	3.21e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	2.87e-06	3.21e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	2.87e-06	3.21e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	2.87e-06	3.21e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—INS—type 2 diabetes mellitus	2.87e-06	3.21e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	2.86e-06	3.19e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	2.85e-06	3.19e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	2.85e-06	3.18e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.85e-06	3.18e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GCG—type 2 diabetes mellitus	2.84e-06	3.18e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	2.84e-06	3.18e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	2.83e-06	3.16e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	2.82e-06	3.15e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	2.82e-06	3.15e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	2.82e-06	3.15e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	2.82e-06	3.15e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	2.8e-06	3.13e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	2.8e-06	3.13e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	2.8e-06	3.12e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	2.79e-06	3.12e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	2.79e-06	3.12e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	2.78e-06	3.1e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.75e-06	3.07e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.74e-06	3.06e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.74e-06	3.06e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	2.71e-06	3.03e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	2.7e-06	3.02e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	2.7e-06	3.01e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.68e-06	2.99e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	2.68e-06	2.99e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.68e-06	2.99e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	2.68e-06	2.99e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	2.65e-06	2.96e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	2.64e-06	2.95e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	2.64e-06	2.95e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—type 2 diabetes mellitus	2.63e-06	2.94e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.63e-06	2.94e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	2.62e-06	2.92e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.6e-06	2.9e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.6e-06	2.9e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	2.59e-06	2.9e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	2.59e-06	2.89e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—INS—type 2 diabetes mellitus	2.59e-06	2.89e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	2.59e-06	2.89e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.58e-06	2.88e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	2.58e-06	2.88e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	2.58e-06	2.88e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.57e-06	2.87e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	2.57e-06	2.87e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	2.56e-06	2.86e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SRC—type 2 diabetes mellitus	2.56e-06	2.86e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	2.54e-06	2.83e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.53e-06	2.83e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	2.53e-06	2.82e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	2.52e-06	2.81e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	2.52e-06	2.81e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	2.52e-06	2.81e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.49e-06	2.78e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	2.49e-06	2.78e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	2.49e-06	2.78e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.49e-06	2.78e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.48e-06	2.78e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.48e-06	2.78e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.48e-06	2.78e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.48e-06	2.78e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	2.46e-06	2.75e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.45e-06	2.74e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	2.45e-06	2.74e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GNB3—type 2 diabetes mellitus	2.45e-06	2.74e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.45e-06	2.74e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.45e-06	2.73e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	2.45e-06	2.73e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	2.44e-06	2.73e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	2.43e-06	2.72e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CAT—type 2 diabetes mellitus	2.41e-06	2.69e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	2.39e-06	2.67e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.38e-06	2.66e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	2.37e-06	2.65e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	2.36e-06	2.64e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	2.35e-06	2.63e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	2.34e-06	2.62e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—APOB—type 2 diabetes mellitus	2.34e-06	2.61e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	2.33e-06	2.61e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	2.3e-06	2.57e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	2.29e-06	2.56e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	2.28e-06	2.55e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SRC—type 2 diabetes mellitus	2.28e-06	2.55e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	2.27e-06	2.54e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	2.27e-06	2.54e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.27e-06	2.54e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	2.27e-06	2.53e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	2.25e-06	2.51e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	2.25e-06	2.51e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	2.24e-06	2.51e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—LPL—type 2 diabetes mellitus	2.23e-06	2.49e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	2.23e-06	2.49e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	2.22e-06	2.48e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	2.22e-06	2.48e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.21e-06	2.47e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	2.2e-06	2.45e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	2.18e-06	2.44e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2.18e-06	2.43e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GPX1—type 2 diabetes mellitus	2.18e-06	2.43e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	2.17e-06	2.43e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.15e-06	2.4e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.15e-06	2.4e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	2.15e-06	2.4e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.14e-06	2.39e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CD36—type 2 diabetes mellitus	2.12e-06	2.37e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.11e-06	2.36e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	2.09e-06	2.34e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	2.08e-06	2.32e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.07e-06	2.31e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	2.06e-06	2.3e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.05e-06	2.29e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	2.04e-06	2.28e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.03e-06	2.26e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.03e-06	2.26e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	2.01e-06	2.24e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—type 2 diabetes mellitus	2e-06	2.23e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.99e-06	2.22e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.99e-06	2.22e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.97e-06	2.2e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.97e-06	2.2e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.97e-06	2.2e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPARA—type 2 diabetes mellitus	1.97e-06	2.2e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.96e-06	2.19e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.95e-06	2.18e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	1.93e-06	2.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.93e-06	2.15e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.91e-06	2.14e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AGT—type 2 diabetes mellitus	1.91e-06	2.13e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.91e-06	2.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.9e-06	2.13e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	1.9e-06	2.12e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	1.89e-06	2.11e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CALM1—type 2 diabetes mellitus	1.88e-06	2.1e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—APOE—type 2 diabetes mellitus	1.87e-06	2.09e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.86e-06	2.08e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.85e-06	2.07e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—APOA1—type 2 diabetes mellitus	1.85e-06	2.07e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.83e-06	2.05e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.77e-06	1.98e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.77e-06	1.98e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.77e-06	1.98e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.76e-06	1.97e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	1.74e-06	1.94e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.74e-06	1.94e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.73e-06	1.93e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.72e-06	1.92e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.7e-06	1.9e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.69e-06	1.88e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.67e-06	1.87e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	1.66e-06	1.86e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.66e-06	1.86e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	1.65e-06	1.84e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.64e-06	1.84e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.64e-06	1.83e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPARG—type 2 diabetes mellitus	1.63e-06	1.82e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.63e-06	1.82e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.63e-06	1.82e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.62e-06	1.81e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.62e-06	1.81e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.6e-06	1.79e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.6e-06	1.79e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—INS—type 2 diabetes mellitus	1.6e-06	1.78e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.59e-06	1.77e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—type 2 diabetes mellitus	1.54e-06	1.72e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.53e-06	1.71e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.53e-06	1.71e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.52e-06	1.7e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.49e-06	1.66e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.43e-06	1.59e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—type 2 diabetes mellitus	1.42e-06	1.58e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.4e-06	1.57e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.4e-06	1.57e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.4e-06	1.56e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.32e-06	1.48e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.32e-06	1.48e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.32e-06	1.47e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.3e-06	1.45e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	1.3e-06	1.45e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.28e-06	1.43e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.28e-06	1.43e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.26e-06	1.41e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.23e-06	1.37e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	1.23e-06	1.37e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.23e-06	1.37e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.23e-06	1.37e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.23e-06	1.37e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.2e-06	1.35e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	1.33e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.18e-06	1.32e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.17e-06	1.31e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.29e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.14e-06	1.28e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.13e-06	1.26e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	1.13e-06	1.26e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.12e-06	1.25e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.08e-06	1.21e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.06e-06	1.19e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.04e-06	1.17e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	1.16e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.03e-06	1.15e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.01e-06	1.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.01e-06	1.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	9.98e-07	1.11e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	8.79e-07	9.82e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	8.62e-07	9.64e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	7.91e-07	8.83e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	7.65e-07	8.55e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	7.56e-07	8.45e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	7.56e-07	8.45e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	7.48e-07	8.35e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.92e-07	7.73e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—type 2 diabetes mellitus	6.44e-07	7.2e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	5.64e-07	6.3e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.48e-07	3.88e-06	CbGpPWpGaD
